Rankings
▼
Calendar
VCEL FY 2024 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$237M
+20.1% YoY
Gross Profit
$172M
72.6% margin
Operating Income
$5M
1.9% margin
Net Income
$10M
4.4% margin
EPS (Diluted)
$0.20
Cash Flow
Operating Cash Flow
$58M
Free Cash Flow
-$6M
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$433M
Total Liabilities
$141M
Stockholders' Equity
$292M
Cash & Equivalents
$75M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$237M
$198M
+20.1%
Gross Profit
$172M
$136M
+26.9%
Operating Income
$5M
-$6M
+169.9%
Net Income
$10M
-$3M
+425.6%
← Q4 2023
All Quarters
Q1 2024 →